From Evidence-based Medicine to Personalized Medicine.

J Korean Soc Coloproctol · 2012 · PMC3499422 · PMID 23185701

Europe PMC DOI

hedged sentence

0.0130

closest p · 0.3× alpha

0.0130

boldest claim

The sentences

showed a trendP = 0.013actually significant

The subgroup analysis of the NSABP C-07 trial showed a trend towards better disease-free survival in patients younger than age 70 (hazard ratio, 0.80; 95% confidence interval, 0.68 to 0.95; P = 0.013), but no positive effect was evident in older patients with the addition of oxaliplatin to the FL regimen [ 10 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.